N@N

CDEX Inc.: CDEX Ships First ID2 Meth Scanners(TM) Sold by Decatur Electronics to Law Enforcement Clients

^{Published on 2009-04-15 06:29:16, Last Modified on 2009-11-03 07:52:30 - Market Wire}
 

TUCSON, AZ--(Marketwire - April 15, 2009) - CDEX Inc. (OTCBB: [ CEXI ]), [ www.cdexinc.com ], announces that today it shipped the first ID2 Meth Scanners™ sold by Decatur Electronics to Law Enforcement Clients. The ID2 Meth Scanner is a handheld, battery-operated device that detects trace quantities of methamphetamine while in the scan mode. Decatur Electronics ([ www.decaturradar.com ]) is the exclusive distributor of the ID2 Meth Scanner to the law enforcement market in North America and a nonexclusive worldwide distributor. For more information, please visit [ http://www.decaturradar.com/decatur/news_profile.php?id=55 ].

"We believe that this first shipment of ID2 Meth Scanners for Decatur clients signifies a major milestone as the Scanner expands its role in the fight against illegal drugs," said Kris Pearson, Marketing Manager for Decatur Electronics.

"This fight is equally intense on Indian Reservations, which is why the Bureau of Indian Affairs elected to purchase Scanners for their use," said Matt Stratton, CDEX's Manager of Marketing Development. "As the dangers of methamphetamine use and passive exposure to meth become better understood, we believe that the Property Inspection markets including inspection of houses, apartments, hotels and used autos, will continue to grow at an accelerated pace."

About CDEX

CDEX develops, manufactures and globally distributes products to the healthcare and security markets. The ValiMed™ product line provides life-saving validation of high-risk medications and returned narcotics. The ID2™ product line detects trace amounts of illegal drugs, such as methamphetamine. CDEX expects to advance its patented technologies to serve additional markets. To meet its plans, CDEX must strengthen its financial position as stated periodically in its SEC filings. For more information, visit [ www.cdexinc.com ].

Non-historical statements are forward-looking, as defined in federal securities laws, and generally can be identified by words such as "expects," "plans," "may," "believes," "should," "intends," and similar words. These statements pose risks and uncertainties that cannot be accurately predicted or quantified and, consequently, actual results may differ materially from those expressed or implied. Such risks and uncertainties include, without limitation, the effectiveness, profitability and marketability of products, the protection of intellectual property and proprietary information, and other risks detailed periodically in filings with the SEC. There is no obligation to update any forward-looking statements.